- ￥7050.90 - 11300.90
- 阿拉丁
- 上海
- V646357
- 2026年01月06日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20°C储存
- 英文名：
Vanilloid receptor antagonist 1
- 库存：
期货
- 供应商：
上海阿拉丁生化科技股份有限公司
- CAS号：
871814-52-7
- 规格：
V646357-50mg/V646357-25mg
| 规格： | V646357-50mg | 产品价格： | ￥11300.9 |
|---|---|---|---|
| 规格： | V646357-25mg | 产品价格： | ￥7050.9 |
英文名：Vanilloid receptor antagonist 1
纯度或规格：≥98%
SPU：V646357
CAS：871814-52-7
存储温度：-20°C储存
运输条件：超低温运输
查看阿拉丁官网此产品相关对应页面：
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Chemokine Receptor Antagonist Development
This chapter describes assays that focus on the characterization of compounds identified in high-�throughput screening campaigns, and the subsequent medicinal chemistry programs. They cover methods to determine potency
Developing a Photoreactive Antagonist
approach for developing small molecules that, upon irradiation with light, may be used to rapidly inactivate targeted proteins expressed on the surfaces of cells. Highlighted is ANQX, a photoreactive AMPA receptor antagonist developed to irreversibly
Prasugrel: A Novel Platelet ADP P2Y12 Receptor Antagonist
than clopidogrel without an unacceptable increase in hemorrhagic or other side effects. Prasugrel (CS-747; LY-640315), a novel third-generation oral thienopyridine, is a specific, irreversible antagonist of the platelet ADP P2Y12 receptor. Pre-clinical and early
技术资料暂无技术资料 索取技术资料
